|
Jul 17
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Jul 17
|
US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation
|
|
Jul 16
|
Trump threatens tariffs on medicines within weeks
|
|
Jul 15
|
Merck Starts Phase III Studies on Once-Monthly Pill for HIV Prevention
|
|
Jul 15
|
Chronic Rhinosinusitis with Nasal Polyps Market Analysis and Forecast Report 2025-2035, Featuring AstraZeneca, Amgen, GlaxoSmithKline, Keymed Biosciences, Biohaven Pharmaceuticals, Sanofi, and More
|
|
Jul 14
|
FDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults
|
|
Jul 12
|
FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
|
|
Jun 26
|
Ephicacy Appoints Névine Zariffa to Its Board of Directors
|
|
Jun 25
|
Bharat, GSK to halve price of malaria vaccine by 2028
|
|
Jun 24
|
EMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related Itch
|
|
Jun 24
|
FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis
|
|
Jun 23
|
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
|
|
Jun 19
|
FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention
|
|
Jun 18
|
GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?
|
|
Jun 17
|
Here's Why GSK (GSK) is a Strong Momentum Stock
|
|
Jun 17
|
GSK Licenses Shigella Vaccine to Bharat Biotech
|
|
Jun 16
|
GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US
|
|
Jun 13
|
GSK (LSE:GSK) Seeks European Expansion Of RSV Vaccine To Adults 18 And Older
|
|
Jun 11
|
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
|
|
Jun 10
|
Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee
|